/biz/ - Business & Finance

>>15582319
https://www.forbes.com/sites/nathanvardi/2019/06/12/move-over-martin-shkreli-this-pharma-exec-is-accused-of-fixing-prices-on-107-drugs/

>Although court documents don’t identify a mastermind behind this five-year-long price-fixing conspiracy, one person, Maureen Cavanaugh, a former senior vice president at one of the world’s largest generic-drug makers, Teva Pharmaceuticals, stands out as perhaps its most important capo. In the new lawsuit, the states accuse Cavanaugh, the highest-ranking Teva executive named, of colluding to raise prices on 107 different generic drugs. According to state attorneys, she held discussions with subordinates to go over price arrangements with competitors and at least once, in a bit of theatrics, put her hands over her ears, pretending not to hear what was being said.

Teva exec, now working at LCI, is primarily why LCI is involved at all. In comparison with their competitors, assuming LCI is even found guilty, which still has to be proven, LCI will be the least scathed. So, given the burden of proof in civil cases is "preponderance of the evidence", (for you non law fags that just means more likely to be true than not) if LCI is found guilty, it's safe to say that all the others would be found guilty as well. It's also safe to say that, given the circumstances, that being Cavanaugh was a Teva exec, that LCI has a good chance, though not 100%, of being clear and free. If the latter were not the case, but the former, then all of the other generic companies would face fines and penalties steeper than LCI, which puts them ahead of their competitors.